Menopause Ultra
Natural health product licensed in Canada
- Other names
- Five Elements
- Licence holder
- Global Cosmeceuticals Corp.
- NPN or DIN-HM
- 80120171
- Status
- Active licence
- Licence date
- 28 July 2022
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Cyanocobalamine | 25 microgram | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome | 50 mg | Not calculated |
| Rubus idaeus Source : rubus idaeus - fruit Potency : 20 % Ellagic acid | 50 mg | Not calculated |
| Dioscorea villosa | 25 mg | Not calculated |
| Folate Source : L-5-methyltetrahydrofolate | 680 microgram | Not calculated |
| 5,7-Dihydroxyflavone | 30 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 15 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 750 mg Potency : 45 mg ÉAI Isoflavones | 150 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Dioxyde de silicium, Stéarate de magnésium, Cellulose, Carboxyméthyl amidon de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help ease nervous tension (calmative). Used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions (such as rheumatoid arthritis, osteoarthritis and/or fibrositis), and pain associated with neuralgia (such as sciatica). Used in Herbal Medicine to help relieve the pain associated with menstruation. (Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help relieve the pain associated with menstruation as well as premenstrual symptoms. May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats). When used with adequate amounts of calcium and vitamin D, helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. (Provides) An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80120171
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.